Related Announcements

NOT-MD-22-006 - Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities

PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

PAR-19-328 - Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) will participate, effective immediately, in NOT-MD-22-006 - Notice of Special Interest (NOSI): "Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities.

Note that NHLBI is only accepting applications in response to this NOSI that target PA-20-185, NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed). Researchers interested in proposing clinical trials for vaccine hesitancy related to heart, lung, and blood diseases should consult with NHLBI staff and consider PAR-19-328 Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required).

Research priorities for NHLBI include increasing the knowledge base on vaccine hesitancy, and implementation research on adoption, uptake, adherence of vaccine protocols, vaccine hesitancy, community engagement, and reducing health disparities, particularly for populations at higher risk for infectious diseases due to chronic cardiovascular, pulmonary, and blood diseases.

All other aspects of the NOSI remain the same.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact
Xinzhi Zhang, MD, PhD
Center for Translation Research & Implementation Science
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-6865
Email: Xinzhi.Zhang@nih.gov

Grants Management Contact
Anthony Agresti
National Heart, Lung, and Blood Institute (NHLBI)
Telepone: 301-827-8014
Email: agrestia@nhlbi.nih.gov